A closed-loop artificial pancreas controlled by body movements, which includes: a sensor used for detecting blood glucose concentration; an infusion module used for infusing drug into the body; a control module connected to the sensor and the infusion module, respectively; and a sensing module operatively connected to the control module and used to sense or recognize the user's body movements, and different body movements represent different functional instructions, and according to the body movement sensed or recognized by the sensing module, the control module controls the sensor or the infusion module to execute corresponding functional instructions, which enhances the user experience.

Systems for use with a medical device for controlling an infusion device are provided. In one aspect, a system includes an infusion device that is configurable with operating limit parameters for providing medication to a patient, and a limiting system. The limiting system receives laboratory information associated with a patient, compares current operating parameters of the infusion device with the operating limit parameters in view of the laboratory information for the patient before and during administration of the medication to the patient by the infusion device, determines that administration of the medication by the infusion device should be prevented based on comparing the operating parameters with the operating limit parameters in view of the laboratory information and, responsive to determining that the operation should be prevented, prevents the administration of the medication by the infusion device, and generates a notification indicating that the operating limit parameters require modification.

An adapter for releasably attaching a syringe to an injector. The adapter comprises a mounting mechanism positioned at a rear end of the adapter to mount the adapter in a desired position relative to a front wall of the injector; and a syringe carrier section adapted to seat at least a portion of the syringe. The syringe carrier section defines a first opening on a top thereof to allow placement of the syringe therein from the top and a second opening in a rear section thereof to allow the drive member of the injector to communicate forward force to the plunger. A cover portion extends over a rearward end of the first opening and has a first end configured to abut the flange of the syringe when the syringe is positioned within the syringe carrier section.

This invention discloses a method of calculating insulin sensitivity factors for use in calculating insulin doses dynamically as a function of current blood glucose level based on the patient's total daily insulin dose. When the total daily insulin is inserted into the equation, the result is a mathematical function that can be used to estimate the effects of each unit of insulin delivered on a patient's blood glucose level at their current blood glucose level. This mathematical equation is valid over a wide range of diabetic conditions and could be widely used throughout the world at very little cost (and at considerable improvement) to the current technology.

An automated closed-loop blood glucose control system comprises a continuous glucose-monitoring sensor (101), a subcutaneous insulin delivery device (103); and a controller (105) which determines a maximal allowable insulin injection amount and determines an insulin delivery control signal on the basis of the maximal allowable insulin injection amount and the quantity of insulin to inject.

A system and method for imaging an anatomical structure corresponding to an infusion therapy anatomical site includes a processor to execute applications stored in a non-transitory computerreadable medium, the applications includes a first application to receive imaging information corresponding to radiant energy from the infusion therapy anatomical site, a second application to decompose the received imaging information into discrete image components, a third application to receive at least one of patient biographic profile characteristics and infusion therapy parameters, and a fourth application to receive the discrete image components, the patient biographic profile characteristics and the infusion therapy parameters and to provide a recommended clinical intervention based on at least one of the discrete image components, the patient biographic profile characteristics, and the infusion therapy parameters.

A wearable infusion pump allows a user to insert a program key into a housing of the pump to select a continuous dosage rate. Program keys are shaped to close contacts on a printed circuit board within the housing to communicate the selected dosage rate to a microprocessor. In this way, a single disposable pump, sold with one Stock keeping unit (SKU), can be used to deliver a plurality of dosage rates. The disposable pump is provided with an on-board display and a one-button on-board user operable control. In preferred embodiments, the infusion pump according to the invention may be used for continuous delivery of insulin in management of Type II diabetes.

Embodiments of the present disclosure relate to techniques, processes, devices or systems for pump devices for providing a fixed volume of fluid, which is delivered and refilled within one pumping cycle. In one approach, a wearable drug delivery device may include a reservoir for storing a liquid drug, and a delivery pump device including a drive mechanism coupled to the reservoir. The drive mechanism may include a housing having a pump chamber fluidly connected with a channel chamber, an inlet channel operable to deliver the liquid drug from the reservoir to the channel chamber, and an outlet channel operable to expel the liquid drug from the channel chamber. The drive mechanism may further include a resilient sealing member sealing the pump chamber, and a plunger adjacent the resilient sealing member, wherein the plunger is operable to enter the pump chamber to displace the liquid drug from the pump chamber.

Glucose control systems are disclosed. An ambulatory medicament pump that is configured to wirelessly transmit one or more of a plurality of glucose control parameters and glucose control therapy data to a second ambulatory medicament pump is disclosed. A control system for transferring historical pump data from a first ambulatory medicament pump to a second ambulatory medicament pump is also disclosed. The control system can receive the historical pump data from a first ambulatory medicament pump, determine that at least one of a plurality of pairing conditions is satisfied to connect the data interface to the second ambulatory medicament pump, transmit, via the data interface, a pairing signal to the second ambulatory medicament pump, and transmit at least one of the therapy data associated with the delivery of the glucose control therapy or the glucose control parameter.

A system and method for correcting a volume of fluid delivered by a fluid injector during an injection procedure is described. The method included determining and compensating for a volume factor associated with compliance of the fluid injector system and correcting for the volume by one of over-driving the distance that the drive member travels in a fluid reservoir, under-driving the distance that the drive member travels in the fluid reservoir, or lengthening or shortening a fluid delivery time.